
Microbial Gene Editing Services Market
Description
Microbial Gene Editing Services Market
Microbial Gene Editing Services: Market Insights
Microbial gene editing is technology which have the ability to change the DNA of organism. Microbial gene editing is changing the ways for developing new medical treatment. From treating diseases such as sickle cell and HIV to custom pets and designer babies, microbial gene editing has great potential to affect in all the areas of live in the near future. Development of new immunotherapies for disease such as cancer as the rising prevalence of cancer which will significantly grow in the future will provide opportunity for the microbial gene editing. For instance, the first-ever human trials of CRISPR focused on treating a various cancers in China and the first human trials for CRISPR tech in the US set to focus on disease such as sickle cell. Progress in availability of computational tools and wet-lab genome editing (GE) technologies have greatly expanded the capability for the complex requirements of system-level investigation of microbes. Microbial gene editing tools such as targetrons, zinc finger nucleases (ZFNs), meganucleases (MNs), (CRISPR)-associated nuclease Cas9 and transcription activator-like effector nucleases (TALENs), and, creates huge opportunity for the gene editing in the forecast period. All these tools can achieve accurate and precise genetic modifications by inducing targeted DNA double strand breaks.
Microbial Gene Editing Services: Market Dynamics
Recent research and development in genome editing technologies hold promise in the forecast period for the development of innovative therapies. Use of genome tools has the potential to affect various therapeutic areas and hundreds of disease, common and rare disease which will significantly boost the market of microbial gene editing services in the forecast period. Increased attention given for the development of new antimicrobials which fight against antibiotic-resistant bacteria will drive the market for microbial gene editing services in near future. For instance, Companies such as Nemesis Bioscience and Eligo Bioscience are developing antimicrobial technology and treatments with the help of CRISPR technology. Increasing government funding and development of fast and east methods with high efficiency spur the microbial gene editing services market in forecast period. However, certain limitations to the available tool and high cost associated with the editing systems might restraint the growth of microbial gene editing services market.
Microbial Gene Editing Services: Segmentation
The global Microbial Gene Editing Services Market is segmented on basis of tools, application and geography.
Segmentation by Tools
Meganucleases (MNs),
Zinc Finger Nucleases (ZFNs)
Transcription Activator-Like Effector Nucleases (TALENs)
CRISPR/Cas9
Targetrons
Peptide Nucleic Acids (PNAs)
Triplex-Forming Oligonucleotides (TFOs)
Structure-Guided Endonucleases(SGNs)
Segmentation by Application
Industrial Applications
Pharmaceutical applications
Environmental applications
Agricultural applications
Segmentation by End User
Biotechnological Companies
Pharmaceutical Companies
Contract Research Organizations
Academic Research Institutes
Microbial Gene Editing Services: Overview
Rising acceptance and increasing medical research and development for gene editing will rise the growth of market in the near future. Growth of established and new gene editing tools is expected to spur the overall market of microbial gene editing services market. Rising clinical trial for diseases as diverse as muscular dystrophy, cancer, and sickle cell anaemia will further drive the microbial gene editing services market. There are approximately 2,700 clinical trials using gene therapies under way or approved around the world. Furthermore increasing number of skilled labors will create opportunity for development of new tools in future which will bring significant growth in the revenue of microbial gene editing services market in the forecast period.
Microbial Gene Editing Services: Region-wise Outlook
The North America market for Microbial Gene Editing Services holds the largest revenue share, due to increasing research and development and rising government funding towards the microbial gene editing research. For instance, in 2018, The US National Institutes of Health (NIH) has announced to grant US$190 million for genome editing research. Launch of genome editing program by NIH such as Somatic Cell Genome Editing programs which aims to develop tools for safe and effective genome editing in humans spur the market of North America in the forecast period. Europe accounts for the second large revenue share in the global microbial gene editing services market, owing to increasing prevalence of disease such as HIV and Cancer and development of new innovative technology and new drug along with the increasing number skilled labors. Asia Pacific is expected to witness rapid growth in the microbial gene editing services market, due to increasing awareness in the gene editing services in developing countries such as India and improving healthcare infrastructure. China is expected to register significant growth in the microbial gene editing services market, due to favorable regulations and advancement in the biotechnology. For instance, the world’s first genetically edited babies was created in China in 2018. Latin America and Middle East & Africa are projected to exhibit slow growth in microbial gene editing services market, owing to lack of R&D labs, awareness and high cost of gene editing tools and systems
Microbial Gene Editing Services: Key Players
Examples of some of the key service provider present in the global microbial gene editing services market are Creative Biogene, GeneCopoeia, Inc., ProteoGenix, Thermo Fisher Scientific Inc., Vigene Biosciences Inc., Biotools Co., Ltd, Cellecta, In, NemaMetrix Inc., GenScript Biotech Corp, OriGene Technologies, Inc, Synbio Technologies LLC, abm Inc, Rockland Immunochemicals Inc.among others.
The report covers exhaustive analysis on,
Microbial Gene Editing Services Market Segments
Microbial Gene Editing Services Market Dynamics
Historical Actual Market Size, 2012 – 2016
Microbial Gene Editing Services Market Size & Forecast 2016 to 2024
Microbial Gene Editing Services Market Current Trends/Issues/Challenges
Competition & Companies involved
Microbial Gene Editing Services Market Drivers and Restraints
Regional analysis includes
North America
Latin America
Europe
Asia Pacific Excluding China
China
Middle East & Africa
Report Highlights:
Shifting Industry dynamics
In-depth market segmentation
Historical, current and projected industry size Recent industry trends
Key Competition landscape
Strategies of key players and product offerings
Potential and niche segments/regions exhibiting promising growth
A neutral perspective towards market performance
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.
Table of Contents
270 Pages
- 1. Executive Summary | Microbial Gene Editing Services Market
- 1.1. Global Market Outlook
- 1.2. Demand-side Trends
- 1.3. Supply-side Trends
- 1.4. Technology Roadmap Analysis
- 1.5. Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
- 3. Market Background
- 3.1. Market Dynamics
- 3.1.1. Drivers
- 3.1.2. Restraints
- 3.1.3. Opportunity
- 3.1.4. Trends
- 3.2. Scenario Forecast
- 3.2.1. Demand in Optimistic Scenario
- 3.2.2. Demand in Likely Scenario
- 3.2.3. Demand in Conservative Scenario
- 3.3. Opportunity Map Analysis
- 3.4. Investment Feasibility Matrix
- 3.5. Value Chain Analysis
- 3.5.1. Profit Margin Analysis
- 3.5.2. Service Providers
- 3.6. PESTLE and Porter’s Analysis
- 3.7. Regulatory Landscape
- 3.7.1. By Key Regions
- 3.7.2. By Key Countries
- 3.8. Regional Parent Market Outlook
- 4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032
- 4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021
- 4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032
- 4.2.1. Y-o-Y Growth Trend Analysis
- 4.2.2. Absolute $ Opportunity Analysis
- 5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Tools
- 5.1. Introduction / Key Findings
- 5.2. Historical Market Size Value (US$ Million) Analysis By Tools, 2017 to 2021
- 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Tools, 2022 to 2032
- 5.3.1. Meganucleases
- 5.3.2. Zinc Finger Nucleases
- 5.3.3. Transcription Activator-Like Effector Nucleases
- 5.3.4. CRISPR/Cas9
- 5.3.5. Targetrons
- 5.3.6. Peptide Nucleic Acids
- 5.3.7. Triplex-Forming Oligonucleotides
- 5.3.8. Structure-Guided Endonucleases
- 5.4. Y-o-Y Growth Trend Analysis By Tools, 2017 to 2021
- 5.5. Absolute $ Opportunity Analysis By Tools, 2022 to 2032
- 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application
- 6.1. Introduction / Key Findings
- 6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2017 to 2021
- 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2022 to 2032
- 6.3.1. Industrial Applications
- 6.3.2. Pharmaceutical Applications
- 6.3.3. Environmental Applications
- 6.3.4. Agricultural Applications
- 6.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2021
- 6.5. Absolute $ Opportunity Analysis By Application, 2022 to 2032
- 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User
- 7.1. Introduction / Key Findings
- 7.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2021
- 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2022 to 2032
- 7.3.1. Biotechnological Companies
- 7.3.2. Pharmaceutical Companies
- 7.3.3. Contract Research Organizations
- 7.3.4. Academic Research Institutes
- 7.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2021
- 7.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032
- 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
- 8.1. Introduction
- 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021
- 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
- 8.3.1. North America
- 8.3.2. Latin America
- 8.3.3. Europe
- 8.3.4. East Asia
- 8.3.5. South Asia & Pacific
- 8.3.6. Middle East and Africa
- 8.4. Market Attractiveness Analysis By Region
- 9. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
- 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
- 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
- 9.2.1. By Country
- 9.2.1.1. USA
- 9.2.1.2. Canada
- 9.2.2. By Tools
- 9.2.3. By Application
- 9.2.4. By End User
- 9.3. Market Attractiveness Analysis
- 9.3.1. By Country
- 9.3.2. By Tools
- 9.3.3. By Application
- 9.3.4. By End User
- 9.4. Key Takeaways
- 10. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
- 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
- 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
- 10.2.1. By Country
- 10.2.1.1. Mexico
- 10.2.1.2. Brazil
- 10.2.1.3. Rest of Latin America
- 10.2.2. By Tools
- 10.2.3. By Application
- 10.2.4. By End User
- 10.3. Market Attractiveness Analysis
- 10.3.1. By Country
- 10.3.2. By Tools
- 10.3.3. By Application
- 10.3.4. By End User
- 10.4. Key Takeaways
- 11. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
- 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
- 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
- 11.2.1. By Country
- 11.2.1.1. Germany
- 11.2.1.2. Italy
- 11.2.1.3. France
- 11.2.1.4. United Kingdom
- 11.2.1.5. Spain
- 11.2.1.6. BENELUX
- 11.2.1.7. Russia
- 11.2.1.8. Rest of Europe
- 11.2.2. By Tools
- 11.2.3. By Application
- 11.2.4. By End User
- 11.3. Market Attractiveness Analysis
- 11.3.1. By Country
- 11.3.2. By Tools
- 11.3.3. By Application
- 11.3.4. By End User
- 11.4. Key Takeaways
- 12. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
- 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
- 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
- 12.2.1. By Country
- 12.2.1.1. China
- 12.2.1.2. Japan
- 12.2.1.3. South Korea
- 12.2.2. By Tools
- 12.2.3. By Application
- 12.2.4. By End User
- 12.3. Market Attractiveness Analysis
- 12.3.1. By Country
- 12.3.2. By Tools
- 12.3.3. By Application
- 12.3.4. By End User
- 12.4. Key Takeaways
- 13. South Asia & Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
- 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
- 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
- 13.2.1. By Country
- 13.2.1.1. India
- 13.2.1.2. ASEAN
- 13.2.1.3. Australia and New Zealand
- 13.2.1.4. Rest of South Asia & Pacific
- 13.2.2. By Tools
- 13.2.3. By Application
- 13.2.4. By End User
- 13.3. Market Attractiveness Analysis
- 13.3.1. By Country
- 13.3.2. By Tools
- 13.3.3. By Application
- 13.3.4. By End User
- 13.4. Key Takeaways
- 14. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
- 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
- 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
- 14.2.1. By Country
- 14.2.1.1. GCC Countries
- 14.2.1.2. Turkey
- 14.2.1.3. South Africa
- 14.2.1.4. Rest of Middle East and Africa
- 14.2.2. By Tools
- 14.2.3. By Application
- 14.2.4. By End User
- 14.3. Market Attractiveness Analysis
- 14.3.1. By Country
- 14.3.2. By Tools
- 14.3.3. By Application
- 14.3.4. By End User
- 14.4. Key Takeaways
- 15. Key Countries Market Analysis
- 15.1. USA
- 15.1.1. Pricing Analysis
- 15.1.2. Market Share Analysis, 2021
- 15.1.2.1. By Tools
- 15.1.2.2. By Application
- 15.1.2.3. By End User
- 15.2. Canada
- 15.2.1. Pricing Analysis
- 15.2.2. Market Share Analysis, 2021
- 15.2.2.1. By Tools
- 15.2.2.2. By Application
- 15.2.2.3. By End User
- 15.3. Mexico
- 15.3.1. Pricing Analysis
- 15.3.2. Market Share Analysis, 2021
- 15.3.2.1. By Tools
- 15.3.2.2. By Application
- 15.3.2.3. By End User
- 15.4. Brazil
- 15.4.1. Pricing Analysis
- 15.4.2. Market Share Analysis, 2021
- 15.4.2.1. By Tools
- 15.4.2.2. By Application
- 15.4.2.3. By End User
- 15.5. Germany
- 15.5.1. Pricing Analysis
- 15.5.2. Market Share Analysis, 2021
- 15.5.2.1. By Tools
- 15.5.2.2. By Application
- 15.5.2.3. By End User
- 15.6. Italy
- 15.6.1. Pricing Analysis
- 15.6.2. Market Share Analysis, 2021
- 15.6.2.1. By Tools
- 15.6.2.2. By Application
- 15.6.2.3. By End User
- 15.7. France
- 15.7.1. Pricing Analysis
- 15.7.2. Market Share Analysis, 2021
- 15.7.2.1. By Tools
- 15.7.2.2. By Application
- 15.7.2.3. By End User
- 15.8. United Kingdom
- 15.8.1. Pricing Analysis
- 15.8.2. Market Share Analysis, 2021
- 15.8.2.1. By Tools
- 15.8.2.2. By Application
- 15.8.2.3. By End User
- 15.9. Spain
- 15.9.1. Pricing Analysis
- 15.9.2. Market Share Analysis, 2021
- 15.9.2.1. By Tools
- 15.9.2.2. By Application
- 15.9.2.3. By End User
- 15.10. BENELUX
- 15.10.1. Pricing Analysis
- 15.10.2. Market Share Analysis, 2021
- 15.10.2.1. By Tools
- 15.10.2.2. By Application
- 15.10.2.3. By End User
- 15.11. Russia
- 15.11.1. Pricing Analysis
- 15.11.2. Market Share Analysis, 2021
- 15.11.2.1. By Tools
- 15.11.2.2. By Application
- 15.11.2.3. By End User
- 15.12. China
- 15.12.1. Pricing Analysis
- 15.12.2. Market Share Analysis, 2021
- 15.12.2.1. By Tools
- 15.12.2.2. By Application
- 15.12.2.3. By End User
- 15.13. Japan
- 15.13.1. Pricing Analysis
- 15.13.2. Market Share Analysis, 2021
- 15.13.2.1. By Tools
- 15.13.2.2. By Application
- 15.13.2.3. By End User
- 15.14. South Korea
- 15.14.1. Pricing Analysis
- 15.14.2. Market Share Analysis, 2021
- 15.14.2.1. By Tools
- 15.14.2.2. By Application
- 15.14.2.3. By End User
- 15.15. India
- 15.15.1. Pricing Analysis
- 15.15.2. Market Share Analysis, 2021
- 15.15.2.1. By Tools
- 15.15.2.2. By Application
- 15.15.2.3. By End User
- 15.16. ASIAN
- 15.16.1. Pricing Analysis
- 15.16.2. Market Share Analysis, 2021
- 15.16.2.1. By Tools
- 15.16.2.2. By Application
- 15.16.2.3. By End User
- 15.17. Australia and New Zealand
- 15.17.1. Pricing Analysis
- 15.17.2. Market Share Analysis, 2021
- 15.17.2.1. By Tools
- 15.17.2.2. By Application
- 15.17.2.3. By End User
- 15.18. GCC Countries
- 15.18.1. Pricing Analysis
- 15.18.2. Market Share Analysis, 2021
- 15.18.2.1. By Tools
- 15.18.2.2. By Application
- 15.18.2.3. By End User
- 15.19. Turkey
- 15.19.1. Pricing Analysis
- 15.19.2. Market Share Analysis, 2021
- 15.19.2.1. By Tools
- 15.19.2.2. By Application
- 15.19.2.3. By End User
- 15.20. South Africa
- 15.20.1. Pricing Analysis
- 15.20.2. Market Share Analysis, 2021
- 15.20.2.1. By Tools
- 15.20.2.2. By Application
- 15.20.2.3. By End User
- 16. Market Structure Analysis
- 16.1. Competition Dashboard
- 16.2. Competition Benchmarking
- 16.3. Market Share Analysis of Top Players
- 16.3.1. By Regional
- 16.3.2. By Tools
- 16.3.3. By Application
- 16.3.4. By End User
- 17. Competition Analysis
- 17.1. Competition Deep Dive
- 17.1.1. Creative Biogene
- 17.1.1.1. Overview
- 17.1.1.2. Product Portfolio
- 17.1.1.3. Profitability by Market Segments
- 17.1.1.4. Sales Footprint
- 17.1.1.5. Strategy Overview
- 17.1.1.5.1. Marketing Strategy
- 17.1.1.5.2. Product Strategy
- 17.1.1.5.3. Channel Strategy
- 17.1.2. GeneCopoeia, Inc.
- 17.1.2.1. Overview
- 17.1.2.2. Product Portfolio
- 17.1.2.3. Profitability by Market Segments
- 17.1.2.4. Sales Footprint
- 17.1.2.5. Strategy Overview
- 17.1.2.5.1. Marketing Strategy
- 17.1.2.5.2. Product Strategy
- 17.1.2.5.3. Channel Strategy
- 17.1.3. ProteoGenix
- 17.1.3.1. Overview
- 17.1.3.2. Product Portfolio
- 17.1.3.3. Profitability by Market Segments
- 17.1.3.4. Sales Footprint
- 17.1.3.5. Strategy Overview
- 17.1.3.5.1. Marketing Strategy
- 17.1.3.5.2. Product Strategy
- 17.1.3.5.3. Channel Strategy
- 17.1.4. Thermo Fisher Scientific Inc.
- 17.1.4.1. Overview
- 17.1.4.2. Product Portfolio
- 17.1.4.3. Profitability by Market Segments
- 17.1.4.4. Sales Footprint
- 17.1.4.5. Strategy Overview
- 17.1.4.5.1. Marketing Strategy
- 17.1.4.5.2. Product Strategy
- 17.1.4.5.3. Channel Strategy
- 17.1.5. Charles River
- 17.1.5.1. Overview
- 17.1.5.2. Product Portfolio
- 17.1.5.3. Profitability by Market Segments
- 17.1.5.4. Sales Footprint
- 17.1.5.5. Strategy Overview
- 17.1.5.5.1. Marketing Strategy
- 17.1.5.5.2. Product Strategy
- 17.1.5.5.3. Channel Strategy
- 17.1.6. Biotools Co., Ltd
- 17.1.6.1. Overview
- 17.1.6.2. Product Portfolio
- 17.1.6.3. Profitability by Market Segments
- 17.1.6.4. Sales Footprint
- 17.1.6.5. Strategy Overview
- 17.1.6.5.1. Marketing Strategy
- 17.1.6.5.2. Product Strategy
- 17.1.6.5.3. Channel Strategy
- 17.1.7. Cellecta, Inc
- 17.1.7.1. Overview
- 17.1.7.2. Product Portfolio
- 17.1.7.3. Profitability by Market Segments
- 17.1.7.4. Sales Footprint
- 17.1.7.5. Strategy Overview
- 17.1.7.5.1. Marketing Strategy
- 17.1.7.5.2. Product Strategy
- 17.1.7.5.3. Channel Strategy
- 17.1.8. InVivo Biosystems
- 17.1.8.1. Overview
- 17.1.8.2. Product Portfolio
- 17.1.8.3. Profitability by Market Segments
- 17.1.8.4. Sales Footprint
- 17.1.8.5. Strategy Overview
- 17.1.8.5.1. Marketing Strategy
- 17.1.8.5.2. Product Strategy
- 17.1.8.5.3. Channel Strategy
- 17.1.9. GenScript Biotech Corp
- 17.1.9.1. Overview
- 17.1.9.2. Product Portfolio
- 17.1.9.3. Profitability by Market Segments
- 17.1.9.4. Sales Footprint
- 17.1.9.5. Strategy Overview
- 17.1.9.5.1. Marketing Strategy
- 17.1.9.5.2. Product Strategy
- 17.1.9.5.3. Channel Strategy
- 17.1.10. OriGene Technologies, Inc.
- 17.1.10.1. Overview
- 17.1.10.2. Product Portfolio
- 17.1.10.3. Profitability by Market Segments
- 17.1.10.4. Sales Footprint
- 17.1.10.5. Strategy Overview
- 17.1.10.5.1. Marketing Strategy
- 17.1.10.5.2. Product Strategy
- 17.1.10.5.3. Channel Strategy
- 17.1.11. Synbio Technologies LLC
- 17.1.11.1. Overview
- 17.1.11.2. Product Portfolio
- 17.1.11.3. Profitability by Market Segments
- 17.1.11.4. Sales Footprint
- 17.1.11.5. Strategy Overview
- 17.1.11.5.1. Marketing Strategy
- 17.1.11.5.2. Product Strategy
- 17.1.11.5.3. Channel Strategy
- 17.1.12. ABM Inc
- 17.1.12.1. Overview
- 17.1.12.2. Product Portfolio
- 17.1.12.3. Profitability by Market Segments
- 17.1.12.4. Sales Footprint
- 17.1.12.5. Strategy Overview
- 17.1.12.5.1. Marketing Strategy
- 17.1.12.5.2. Product Strategy
- 17.1.12.5.3. Channel Strategy
- 17.1.13. Rockland Immunochemicals Inc.
- 17.1.13.1. Overview
- 17.1.13.2. Product Portfolio
- 17.1.13.3. Profitability by Market Segments
- 17.1.13.4. Sales Footprint
- 17.1.13.5. Strategy Overview
- 17.1.13.5.1. Marketing Strategy
- 17.1.13.5.2. Product Strategy
- 17.1.13.5.3. Channel Strategy
- 18. Assumptions & Acronyms Used
- 19. Research Methodology
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.